Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Pharmavite Announces $425 Million Acquisition of Bonafide Health to Become Leader in Women’s Health
Life Sciences Times
-
November 30, 2023
0
Venture Capital
Johnson & Johnson MedTech Acquires Laminar, Inc.
Life Sciences Times
-
November 30, 2023
0
Venture Capital
QPS Holdings, LLC divests its Neuropharmacology Business Unit
Life Sciences Times
-
November 30, 2023
0
Venture Capital
Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth
Life Sciences Times
-
November 30, 2023
0
Venture Capital
Accenture to Acquire Rabbit’s Tale to Strengthen Its Creative & Digital Customer Experience Capabilities in Southeast Asia
Life Sciences Times
-
November 29, 2023
0
Venture Capital
Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs
Life Sciences Times
-
November 27, 2023
0
Real Estate
Onelife Enters Chicago With Acquisition of The Laurel at Vernon Hills Memory Care
Life Sciences Times
-
November 27, 2023
0
Venture Capital
Curi Capital to Merge with RMB Capital
Life Sciences Times
-
November 21, 2023
0
Venture Capital
Aether Biomedical Announces Series A Funding Round Close, Pushes Forward Future of Upper Limb Prosthetics
Life Sciences Times
-
November 13, 2023
0
Venture Capital
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Life Sciences Times
-
November 13, 2023
0
Venture Capital
Ontrak, Inc. Announces Pricing of $6.3 Million Public Offering, $11 Million Concurrent Private Placement and $16.3 Million Conversion of Secured Notes
Life Sciences Times
-
November 10, 2023
0
People on the Move
Vida Health Announces $28.5 Million in Funding; Appoints Joe Murad CEO
Life Sciences Times
-
November 10, 2023
0
1
...
37
38
39
...
115
Page 38 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026